Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many immunocompromised people have (a) been hospitalised with and (b) died from covid-19 since the MHRA authorised Evusheld for use in the UK.
The information requested is not held centrally.
On 17 March 2022, the Medicines and Healthcare products Regulatory Agency granted a conditional marketing authorisation for Evusheld. However, this authorisation outlined uncertainties for the treatment, including the length of protection and the dose required for efficacy against the Omicron variant.